University of Tennessee Health Science Center
University of Tennessee Health Science Center
Memphis, Tennessee, United States5 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endometrium neoplasm, female reproductive system disorder, female reproductive system neoplasm, neoplasm, uterine disorder | Active, not recruiting | Phase 3 | 2026-09-30 | NCT05611931 | |
| Investigations of Reproductive Cancers in Women | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, female reproductive system disorder, female reproductive system neoplasm, neoplasm, uterine cancer, uterine disorder | Recruiting | Not stated | 2026-08-17 | NCT06527157 | |
| A Single-arm, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of P1101 in Adults With ET | Hemic and Lymphatic Diseases, Myeloproliferative Disorders, blood coagulation disease, blood platelet disease, bone marrow disorder, essential thrombocythemia, hematologic disorder, hemorrhagic disease, neoplasm, thrombocytosis disease | Active, not recruiting | Phase 2 | 2025-08-13 | NCT05482971 | |
| A Study to Assess Efficacy, Safety, and Tolerability of P1101 in Adult Patients With PV | Hemic and Lymphatic Diseases, Myeloproliferative Disorders, Neoplasms by Site, acquired polycythemia vera, blood coagulation disease, blood platelet disease, bone marrow disorder, bone marrow neoplasm, essential thrombocythemia, hematologic disorder, hematopoietic and lymphoid system neoplasm, hemorrhagic disease, neoplasm, polycythemia, thrombocytosis disease | Active, not recruiting | Phase 3 | 2025-08-13 | NCT05481151 | |
| Multi-Institutional IMPACT Validation | Craniocerebral Trauma, Facial Injuries, Mandibular Fractures, Maxillofacial Injuries, Orbital Fractures, Skull Fractures, Stomatognathic Diseases, Tooth, Impacted, Zygomatic Fractures, bone fracture, injury, jaw fracture, nervous system disorder, nervous system injury, tooth disorder | Enrolling by invitation | Not stated | 2025-06-18 | NCT06850857 |